Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [2]
- Immunocytochemistry [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN261460 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Aggrecan (ACAN) (AA 350-400) antibody
- Antibody type
- Polyclonal
- Description
- Immunogen affinity purified
- Reactivity
- Human, Mouse, Rat, Bovine, Canine, Porcine
- Host
- Rabbit
- Epitope
- AA 350-400
- Vial size
- 0.1 mL
- Storage
- Store at -20°C. Avoid freeze-thaw cycles.
- Handling
- Avoid freeze-thaw cycles
Submitted references Physiological concentrations of soluble uric acid are chondroprotective and anti-inflammatory.
Exosomes from embryonic mesenchymal stem cells alleviate osteoarthritis through balancing synthesis and degradation of cartilage extracellular matrix.
Lubricin protects the temporomandibular joint surfaces from degeneration.
A benzamide-linked small molecule HS-Cf inhibits TNF-α-induced interferon regulatory factor-1 in porcine chondrocytes: a potential disease-modifying drug for osteoarthritis therapeutics.
Advanced glycation end products cause collagen II reduction by activating Janus kinase/signal transducer and activator of transcription 3 pathway in porcine chondrocytes.
Lai JH, Luo SF, Hung LF, Huang CY, Lien SB, Lin LC, Liu FC, Yen BL, Ho LJ
Scientific reports 2017 May 24;7(1):2359
Scientific reports 2017 May 24;7(1):2359
Exosomes from embryonic mesenchymal stem cells alleviate osteoarthritis through balancing synthesis and degradation of cartilage extracellular matrix.
Wang Y, Yu D, Liu Z, Zhou F, Dai J, Wu B, Zhou J, Heng BC, Zou XH, Ouyang H, Liu H
Stem cell research & therapy 2017 Aug 14;8(1):189
Stem cell research & therapy 2017 Aug 14;8(1):189
Lubricin protects the temporomandibular joint surfaces from degeneration.
Hill A, Duran J, Purcell P
PloS one 2014;9(9):e106497
PloS one 2014;9(9):e106497
A benzamide-linked small molecule HS-Cf inhibits TNF-α-induced interferon regulatory factor-1 in porcine chondrocytes: a potential disease-modifying drug for osteoarthritis therapeutics.
Liu FC, Huang HS, Huang CY, Yang R, Chang DM, Lai JH, Ho LJ
Journal of clinical immunology 2011 Dec;31(6):1131-42
Journal of clinical immunology 2011 Dec;31(6):1131-42
Advanced glycation end products cause collagen II reduction by activating Janus kinase/signal transducer and activator of transcription 3 pathway in porcine chondrocytes.
Huang CY, Lai KY, Hung LF, Wu WL, Liu FC, Ho LJ
Rheumatology (Oxford, England) 2011 Aug;50(8):1379-89
Rheumatology (Oxford, England) 2011 Aug;50(8):1379-89
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- Figure 1 illustrates immunostaining of OA ABIN261460.
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC